When it might not be the flare: a 2026 expert update on C. difficile infection in IBD

Inflammatory bowel disease — ulcerative colitis and Crohn's disease, mostly — is a long-term condition where parts of the digestive system become inflamed. The symptoms are familiar to anyone living with it: diarrhoea, urgency, blood, cramping, the tiredness that comes with all of it, arriving and easing in what most people just call a flare [1].

Here is the quiet problem at the centre of this story. There is a gut infection that produces almost the same picture. Clostridioides difficile — C. difficile, or C. diff — is a bacterial infection of the bowel that causes diarrhoea. It often follows a course of antibiotics, is more common in people who have spent time in hospital or other healthcare settings, and can sometimes become serious [2]. Diarrhoea, cramping, urgency: from the outside, a C. diff infection and an IBD flare can look remarkably alike.

That overlap is not a small footnote. In 2026 the American Gastroenterological Association published a Clinical Practice Update — an expert review — devoted specifically to managing C. difficile infection in people who also have IBD, in the journal Gastroenterology [3].

It's worth being precise about what kind of source that is. A Clinical Practice Update is expert consensus guidance: a panel of specialists synthesising the available evidence into practical recommendations for clinicians. That is not the same as a single new trial, and we shouldn't read it as a breakthrough. But it is also not a lone study — in the hierarchy of evidence, society practice guidance like this is the kind of source that outranks any one paper, because it weighs the whole field. When a body the size of the AGA writes a dedicated update on one narrow intersection, the signal is that the intersection itself is common enough, and tricky enough, to deserve its own playbook [3].

And the reason it's tricky is the part worth carrying away. Because a C. difficile infection and an IBD flare can present so similarly, separating the two is a question that gets answered by testing and clinical assessment — not by reading the symptoms and assuming. The distinction matters because it changes what should happen next: an infection and a flare are not managed the same way, and treating one as if it were the other is precisely the failure mode that dedicated guidance is written to prevent [4].

So the honest takeaway here is modest and useful at the same time. This isn't news that anything has changed about IBD itself, and it isn't a reason for alarm. It's a reason to know one fact: when a flare arrives that feels different — after a course of antibiotics, after a hospital stay, or simply not behaving the way your flares usually do — "it's probably just the flare" is an assumption a clinician should get to test, not one to settle on at home. We're not here to tell you what that testing should be or what any result means; the existence of an expert update on exactly this question is the clearest possible sign that it belongs with your IBD team, with your history in front of them — not with us, and not with a search bar.